杨文杰,陈艳红,张勇华,屈璐璐,苏晞

• 1:武汉亚洲心脏病医院心内科

摘要(Abstract)：

目的 探讨左心耳封堵术后器械相关血栓形成的发生率、影响因素及其临床预后。方法 纳入2014年5月至2018年6月在武汉亚洲心脏病医院心内科接受左心耳封堵术并完成术后45 d经食管超声心动图检查的患者308例。根据术后45 d经食管超声心动图检查是否存在器械相关血栓形成分为器械相关血栓组和无器械相关血栓组。收集并比较两组患者的基线资料、术中资料、术后45 d随访资料及术后中长期随访资料。结果 术后45 d经食管超声心动图检查发现7例器械相关血栓形成，左心耳封堵术后器械相关血栓形成的发生率为2.3%(7/308）。两组患者的年龄、性别、身体质量指数、心房颤动类型、高血压病、糖尿病、冠心病、心力衰竭、CHA_2DS_2-VASc评分、左心房内径、左心耳口径及左心耳体长等基线资料比较，差异均无统计学意义（均P>0.05）。与无器械相关血栓组相比，器械相关血栓组的卒中史占比较高（85.7%比42.5%,P=0.058),HAS-BLED评分较高[（2.6±1.0）分比（1.9±1.1）分，P=0.078]，但差异均无统计学意义。两组患者术后即刻残余分流、术后45 d残余分流、封堵器类型及术后抗栓方案比较，差异均无统计学意义（均P>0.05）。多因素Logistic回归分析显示，卒中史是器械相关血栓形成的独立危险因素（OR 8.1,P=0.019）。在术后平均826 d随访时，两组患者的全因死亡率、总出血发生率、脑出血发生率及小出血发生率等比较，差异均无统计学意义（均P>0.05）。与无器械相关血栓组相比，器械相关血栓组的卒中发生率较高（14.3%比1.0%,P=0.092），但差异无统计学意义。然而Kaplan-Meier生存曲线分析结果显示，器械相关血栓形成与卒中事件发生密切相关（HR 16.8,P<0.001）。结论 左心耳封堵术后器械相关血栓形成并不常见，卒中史是器械相关血栓形成的独立危险因素，器械相关血栓形成会增加卒中的风险。

关键词(KeyWords)： 左心耳封堵术;器械相关血栓形成;影响因素;卒中

Abstract:

Keywords:

基金项目(Foundation): 2020武汉市卫生健康委科研项目（WX20C28）

作者(Author): 杨文杰,陈艳红,张勇华,屈璐璐,苏晞

参考文献(References)：

• [1] Flegel KM, Shipley MJ, Rose G. Risk of stroke in nonrheumatic atrial fi brillation[J]. Lancet, 1987, 1(8532):526-529.
• [2] Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fi brillation[J]. Ann Thorac Surg, 1996, 61(2):755-759.
• [3]黄从新，张澍，黄德嘉，等.心房颤动：目前的认识和治疗建议（2018）[J].中华心律失常学杂志，2018, 22(4):279-346.
• [4] Alkhouli M, Busu T, Shah K, et al. Incidence and clinical impact of device-related thrombus following percutaneous left atrial appendage occlusion:a meta-analysis[J]. JACC Clin Electrophysiol, 2018, 4(12):1629-1637.
• [5] Saw J, Nielsen-Kudsk JE, Bergmann M, et al. Antithrombotic therapy and device-related thrombosis following endovascular left atrial appendage closure[J]. JACC Cardiovasc Interv, 2019,12(11):1067-1076.
• [6] Kaneko H, Neuss M, Weissenborn J, et al. Predictors of thrombus formation after percutaneous left atrial appendage closure using the WATCHMAN device[J]. Heart Vessels,2017, 32(9):1137-1143.
• [7] Main ML, Fan D, Reddy VY, et al. Assessment of device-related thrombus and associated clinical outcomes with the WATCHMAN left atrial appendage closure device for embolic protection in patients with atrial fi brillation(from the PROTECTAF Trial)[J]. Am J Cardiol, 2016, 117(7):1127-1134.
• [8] Dukkipati SR, Kar S, Holmes DR, et al. Device-related thrombus after left atrial appendage closure:incidence,predictors, and outcomes[J]. Circulation, 2018, 138(9):874-885.
• [9] Sasko B, Ritter O, Bramlage P, et al. Late left atrial appendage closure device displacement and massive thrombus formation:a case report[J]. Eur Heart J Case Rep, 2020, 4(2):1-5.
• [10] Reddy VY, Holmes D, Doshi SK, et al. Safety of percutaneous left atrial appendage closure:results from the watchman left atrial appendage system for embolic protection in patients with AF(PROTECT AF)clinical trial and the continued access registry[J]. Circulation, 2011, 123(4):417-424.
• [11]中华医学会心血管病学分会，中华心血管病杂志编辑委员会.中国左心耳封堵预防心房颤动卒中专家共识（2019）[J].中华心血管病杂志，2019, 47(12):937-955.
• [12]朱霓，白元，秦永文，等.左心耳封堵术后器械相关血栓形成的原因和防治[J].中华心血管病杂志，2021, 49(2):5.
• [13] Schwartz RS, Holmes DR, Van Tassel RA, et al. Left atrial appendage obliteration:mechanisms of healing and intracardiac integration[J].JACC Cardiovasc Interv, 2010, 3(8):870-877.
• [14] Bass JL. Transcatheter occlusion of the left atrial appendageexperimental testing of a new Amplatzer device[J]. Catheter Cardiovasc Interv, 2010, 76(2):181-185.
• [15] Rodés-Cabau J, O’Hara G, Paradis JM, et al. Changes in coagulation and platelet activation markers following transcatheter left atrial appendage closure[J]. Am J Cardiol, 2017, 120(1):87-91.
• [16] Pracon R, Bangalore S, Dzielinska Z, et al. Device thrombosis after percutaneous left atrial appendage occlusion is related to patient and procedural characteristics but not to duration of postimplantation dual antiplatelet therapy[J]. Circ Cardiovasc Interv, 2018, 11(3):e005997.
• [17] Fauchier L, Cinaud A, Brigadeau F, et al. Device-related thrombosis after percutaneous left atrial appendage occlusion for atrial fibrillation[J]. J Am Coll Cardiol, 2018, 71(14):1528-1536.
• [18] Bai Y, Xue X, Duenninger E, et al. Real-world survival data of device-related thrombus following left atrial appendage closure:4-year experience from a single center[J]. Heart Vessels, 2019, 34(8):1360-1369.
• [19] Saw J, Tzikas A, Shakir S, et al. Incidence and clinical impact of device-associated thrombus and peri-device leak following left atrial appendage closure with the amplatzer cardiac plug[J].JACC Cardiovasc Interv, 2017, 10(4):391-399.
• [20] Kanderian AS, Gillinov AM, Pettersson GB, et al. Success of surgical left atrial appendage closure:assessment by transesophageal echocardiography[J]. J Am Coll Cardiol,2008, 52(11):924-929.
• [21] Viles-Gonzalez JF, Kar S, Douglas P, et al. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation:a PROTECT AF(percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fi brillation)substudy[J]. J Am Coll Cardiol, 2012,59(10):923-929.
• [22]夏林莺，刘毅，陶凌. Watchman封堵器左心耳封堵术后器械相关血栓的发生率及临床转归的Meta分析[J].中国介入心脏病学杂志，2020, 28(3):38-43.
• [23] Cochet H, Iriart X, Sridi S, et al. Left atrial appendage patency and device-related thrombus after percutaneous left atrial appendage occlusion:a computed tomography study[J]. Eur Heart J Cardiovasc Imaging, 2018, 19(12):1351-1361.
• [24] Tzikas A, Shakir S, Gafoor S, et al. Left atrial appendage occlusion for stroke prevention in atrial fi brillation:multicentre e x p e r i e n c e w i t h t h e A M P L AT Z E R C a r d i a c P l u g[J].EuroIntervention, 2016, 11(10):1170-1179.